Several cellular targets have been identified, including CB1 and CB2, though with a relatively low affinity to some cancer cells other than lung, colorectal, and prostate; however, other targets, such as TRPV1, TRPV2, and GPR55, which are highly expressed in cancer cells have been identified as alternatives. This evidence concerns the gene TRPV1 and cancer.